Home / GNL1 Knockout Cell Lines

GNL1 Knockout Cell Lines

Gene: GNL1

Official Full Name: G protein nucleolar 1 (putative)provided by HGNC

Gene Summary: The GNL1 gene, identified in the human major histocompatibility complex class I region, shows a high degree of similarity with its mouse counterpart. The GNL1 gene is located less than 2 kb centromeric to HLA-E, in the same transcriptional orientation. GNL1 is telomeric to HLA-B and HLA-C. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO37591 GNL1 Knockout cell line (HeLa) Human GNL1 1:3~1:6 Negative Online Inquiry
KO37592 GNL1 Knockout cell line (HCT 116) Human GNL1 1:2~1:4 Negative Online Inquiry
KO37593 GNL1 Knockout cell line (HEK293) Human GNL1 1:3~1:6 Negative Online Inquiry
KO37594 GNL1 Knockout cell line (A549) Human GNL1 1:3~1:4 Negative Online Inquiry

Background

GNL1 Gene Knockout Cell Lines are specifically engineered cellular models that lack the GNL1 gene, which encodes the guanine nucleotide-binding protein, pivotal for ribosome biogenesis and cellular proliferation. These knockout cell lines serve as essential tools in elucidating the biological roles of GNL1 in various cellular processes and identifying its contributions to disease mechanisms, particularly in cancer research and cellular response pathways.

The primary function of GNL1 involves transcriptional regulation and the assembly of ribonucleoproteins. The knockout of this gene allows researchers to explore the downstream effects on cellular activities such as protein synthesis, cell cycle regulation, and apoptosis. Through the use of these cell lines, scientists can investigate the impacts of GNL1 depletion on cellular morphology, growth patterns, and gene expression profiles. This can yield insights into pathological states where GNL1 may play a critical role.

In research settings, the GNL1 Gene Knockout Cell Lines provide a powerful platform for studying the consequences of GNL1 loss, including its role in tumorigenesis and resistance to therapeutic interventions. Its relevance extends to pharmaceutical development, where understanding GNL1’s mechanisms can facilitate the discovery of targeted treatments for cancers and other diseases.

Unlike traditional knockdown models, which may not completely ablate gene function and can lead to compensatory responses, the complete knockout offered by these cell lines ensures a more profound understanding of GNL1’s functions. The specificity and effectiveness of these models provide researchers with a robust means of validating experimental results and hypothesis-driven studies.

For researchers and clinicians focused on unraveling complex biological pathways, the GNL1 Gene Knockout Cell Lines represent a valuable asset that enhances the design and execution of high-impact experiments. Backed by our company’s expertise in genetic engineering and deep commitment to advancing scientific inquiry, we offer a reliable tool that stands out in the landscape of biological research products, enabling breakthroughs that can lead to significant advancements in health and medicine.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.